NCT01070459

Brief Summary

This study aims to investigate the effect of aerobic exercise on the aerobic capacity, the daily functioning, post-stroke fatigue , depression and cardiovascular risk factors in stroke patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Feb 2010

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

February 16, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 18, 2010

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

April 14, 2010

Status Verified

April 1, 2010

Enrollment Period

10 months

First QC Date

February 16, 2010

Last Update Submit

April 13, 2010

Conditions

Keywords

Stroke aerobic exercise daily functioning rehabilitation

Outcome Measures

Primary Outcomes (1)

  • VO2-peak, strength, walking, activities of daily living

    baseline , after 12 weeks training. Follow-up measurements after 6 months, 1 and 2 years after baseline.

Secondary Outcomes (1)

  • post-stroke fatigue, depression, lifestyle, cardiovascular risk factors

    baseline , after 12 weeks training. Follow-up measurements after 6 months, 1 and 2 years after baseline.

Study Arms (5)

Control group

PLACEBO COMPARATOR

The patients continue their regular therapy in the rehabilitation center. They participate in a 12-week programme of passive mobilisation of the hemiplegic knee, using a continuous passive motion device. Patients will be trained three times a week, 30 minutes/session.

Behavioral: Follow-up control group

Aerobic exercise group

EXPERIMENTAL

The patients continues their regular therapy in the rehabilitation center. They participate in a 12-week programme of aerobic training 30 minutes/session, using a leg cycle bike. Patients will be trained three times a week. The heart rate will vary from 50 tot 75% of their predicted heart rate. Each patient will be provided with an progressive exercise prescription based on 50-75% of their predicted maximum heartrate. Throughout the training sessions the heart rate will be monitored continuously with a polar pulse rate. Within these 12 week training programme 4 information sessions will be offered to patients and relatives about risk factors of stroke, usefulness of an active lifestyle and healthy eating.

Behavioral: Aerobic exercise groupBehavioral: Follow-up first aerobic exercise groupBehavioral: Follow-up second aerobic exercise group

Follow-up first aerobic exercise group

EXPERIMENTAL
Behavioral: Follow-up first aerobic exercise group

Follow-up control group

PLACEBO COMPARATOR
Behavioral: Control groupBehavioral: Follow-up control group

Follow-up second aerobic exercise group

EXPERIMENTAL
Behavioral: Follow-up second aerobic exercise group

Interventions

The patients continue their regular therapy in the rehabilitation center. They participate in a 12-week programme of aerobic training 30 minutes/session, using a leg cycle bike. Patients will be trained three times a week. The heartrate will vary from 50 tot 75% of their predicted heart rate. Each patient will be provided with an progressive exercise prescription based on 50-75% of their predicted maximum heartrate. Throughout the training sessions the heart rate will be monitored continuously with a polar pulse rate. Within these 12 week exercise programme four information sessions will be offered to patients and relatives about risk factors of stroke, usefulness of an active lifestyle and healthy eating.

Aerobic exercise group
Control groupBEHAVIORAL

The patients continue their regular therapy in the rehabilitation center. They participate in a 12-week programme of passive mobilisation of the hemiplegic knee, using a continuous passive motion device. Patients will be trained three times a week, 30 minutes/session.

Follow-up control group

The experimental aerobic exercise will be divided in two groups at random after the 12 weeks aerobic exercise programme. The first group will get feedback on how to train further their aerobic capacity within the following 9 months. The second group will not undergo the feedback programme.

Aerobic exercise groupFollow-up first aerobic exercise group

No intervention will be offered in a period of 9 months after the passive mobilisation programme

Control groupFollow-up control group

The experimental aerobic exercise will be divided in two groups at random after the 12 weeks aerobic exercise programme. The second group will not undergo the feedback programme. This group will be measured but not treated with an intervention programme

Aerobic exercise groupFollow-up second aerobic exercise group

Eligibility Criteria

AgeUp to 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • First CVA according to the WHO definition (A primary, first ever stroke ash revealed by rapidly developing clinical signs or focal or global disturbance or cerebral function, with symptoms lasting 24 hours or longer or leading to death, with no apparent cause other than or vascular origin.) This includes ischemic infarct or an intracerebral haemorrhage
  • The offense can be maximum 3 up to 6 weeks after onset
  • Patient must be able to follow simple verbal instructions
  • To cycle during 1 minute at 20 Watt, 50RPM,
  • Cardiac stable

You may not qualify if:

  • Have another neurological impairments with permanent damage such as former cranial trauma, multiple sclerosis, epileptic status… which already present were for current CVA
  • Having on CVA resembling symptoms as a result of subdural haemorrhage, a tumour, encephalitis or a trauma
  • Barthel index \< 50 before the stroke onset
  • Age \> 80 year
  • No authorisation form of the patient or of the family
  • Absolute contra-indications for effort test (ACC/AHA guidelines)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Revalidatiecentrum Sint-Ursula

Herk-de-Stad, Limburg, 3540, Belgium

Location

Related Publications (3)

  • Saunders DH, Mead GE, Fitzsimons C, Kelly P, van Wijck F, Verschuren O, Backx K, English C. Interventions for reducing sedentary behaviour in people with stroke. Cochrane Database Syst Rev. 2021 Jun 29;6(6):CD012996. doi: 10.1002/14651858.CD012996.pub2.

  • Vanroy C, Vanlandewijck Y, Cras P, Truijen S, Vissers D, Swinnen A, Bosmans M, Wouters K, Feys H. Does a cycling program combined with education and followed by coaching promote physical activity in subacute stroke patients? A randomized controlled trial. Disabil Rehabil. 2019 Feb;41(4):413-421. doi: 10.1080/09638288.2017.1395084. Epub 2017 Nov 5.

  • Vanroy C, Feys H, Swinnen A, Vanlandewijck Y, Truijen S, Vissers D, Michielsen M, Wouters K, Cras P. Effectiveness of Active Cycling in Subacute Stroke Rehabilitation: A Randomized Controlled Trial. Arch Phys Med Rehabil. 2017 Aug;98(8):1576-1585.e5. doi: 10.1016/j.apmr.2017.02.004. Epub 2017 Mar 8.

MeSH Terms

Conditions

Stroke

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Patrick Cras, prof. dr.

    Universiteit Antwerpen

    STUDY CHAIR
  • Yves Vanlandewijck, prof.dr.

    KU Leuven

    STUDY DIRECTOR
  • Hilde Feys, prof.dr.

    Catholic University of Antwerp

    STUDY DIRECTOR
  • Steven Truijen, dr.

    University college Antwerp

    STUDY DIRECTOR
  • Dirk Vissers, dr.

    University College of Antwerp

    STUDY DIRECTOR
  • christel Vanroy, PhD

    University College Antwerp

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 16, 2010

First Posted

February 18, 2010

Study Start

February 1, 2010

Primary Completion

December 1, 2010

Study Completion

December 1, 2011

Last Updated

April 14, 2010

Record last verified: 2010-04

Locations